Skip to main content

Month: April 2020

BriaCell Files Patent Application for Novel Therapeutics for Cancer

BERKELEY, Calif., and VANCOUVER, British Columbia, April 27, 2020 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (“BriaCell” or the “Company”) (TSX-V:BCT) (OTCQB:BCTXF), a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced breast cancer, announces that it has filed a provisional patent application with the U.S. Patent and Trademark Office (USPTO) outlining the development and use of novel therapeutics (i.e. multi-specific binding reagents) that activate immune cells to selectively destroy the cancer cells or to selectively block cancer cells from inactivating immune cells.The patent application, entitled “METHODS FOR INDUCING AND ENHANCING ANTI-CANCER IMMUNE RESPONSES USING NOVEL MOLECULAR CONSTRUCTS”, outlines the development and use of multi-specific binding reagents that simultaneously bind...

Continue reading

Harpoon Therapeutics Doses First Patient with HPN217, a BCMA Targeting TriTAC, for Multiple Myeloma

SOUTH SAN FRANCISCO, Calif., April 27, 2020 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing a novel class of T cell engagers, today announced that the first patient has been dosed with HPN217 in a Phase 1/2 clinical trial focused on relapsed, refractory multiple myeloma (RRMM). HPN217 is being developed under a global license and option agreement with AbbVie Inc. (NYSE:ABBV) and dosing of the first patient in a clinical trial has triggered a $50 million milestone payment to Harpoon. HPN217 targets B-cell maturation antigen (BCMA), a well-validated antigen expressed on malignant multiple myeloma calls. HPN217 is Harpoon’s third product candidate to enter the clinic and is based on Harpoon’s proprietary Tri-specific T cell Activating Construct (TriTAC™) platform designed...

Continue reading

People Corporation Announces Financial Results for the Second Quarter of Fiscal 2020

WINNIPEG, Manitoba, April 27, 2020 (GLOBE NEWSWIRE) — People Corporation (the “Company”) (TSX Venture: PEO) today announced financial results for the quarter ended February 29, 2020.Laurie Goldberg, Executive Chairman and Chief Executive Officer commented, “People Corporation made solid strategic and financial progress in the second quarter of 2020. Steady execution of our strategy generated revenue growth of 45.5%, and growth in Adjusted EBITDA, of 52.3% compared to the same period last year. Delivering the Company’s unique value proposition for plan sponsors and their members, our team drove organic revenue growth of 15.6% in Q2.  We continue to see substantial opportunity to further leverage our national platform, capitalize on our growing scale and national distribution footprint, and to consistently evolve our product...

Continue reading

PunaMusta Media -konsernin liiketoimintakatsaus, tammi-maaliskuu 2020

PUNAMUSTA MEDIA OYJ PÖRSSITIEDOTE 27.4.2020 KLO 13.30LIIKEVAIHDON KASVU JATKUI Q1:LLA VAHVANA KORONAVIRUKSEEN SAAKKA                     PunaMusta Media Oyj julkistaa liiketoimintakatsauksen, jossa esitetään yhtiön taloudellista kehitystä koskevat keskeiset tiedot. Liiketoimintakatsauksen luvut ovat tilintarkastamattomia.TAMMI-MAALISKUU 2020 LYHYESTI– Konsernin liikevaihto kasvoi 6,7 % ja oli 27,3 miljoonaa euroa (25,6 miljoonaa euroa).– Käyttökate oli 1,6 (2,3) miljoonaa euroa– Liiketulos oli -0,6 (0,5) miljoonaa euroa ja tulos ennen veroja -2,9 (1,8) miljoonaa euroa. – Liiketoiminnan nettorahavirta oli 4,8 (3,7) miljoonaa euroa.– Omavaraisuusaste oli 40,9 % (49,0 %).– Sijoitetun pääoman tuotto ennen veroja oli -3,7 % (2,8 %).– Oman pääoman tuotto verojen jälkeen oli -6,7 % (3,0 %).– Laimentamaton...

Continue reading

Talenom Oyj:n liiketoimintakatsaus tammi­–maaliskuu 2020 (tilintarkastamaton): Liikevaihto kasvoi 17 % ja liikevoitto parani 8 %  –  ensimmäinen vuosineljännes tavoitteiden mukainen

Talenom Oyj, pörssitiedote 27.4.2020 kello 13:30Talenom Oyj:n liiketoimintakatsaus tammi­–maaliskuu 2020 (tilintarkastamaton): Liikevaihto kasvoi 17 % ja liikevoitto parani 8 %  –  ensimmäinen vuosineljännes tavoitteiden mukainen

Continue reading

Armstrong World Industries Reports First Quarter 2020 Results

Key HighlightsNet sales of $248.7 million, up 3% versus the prior year quarterOperating income of $76.0 million, up 39% versus the prior year quarter$1 billion pension risk transfer results in $374.4 million non-cash charge to non-operating incomeAdjusted EBITDA and EPS grew 5% and 10%, respectively, versus the prior year quarterWithdrawing and suspending 2020 guidance due to COVID-19LANCASTER, Pa., April 27, 2020 (GLOBE NEWSWIRE) — Armstrong World Industries, Inc. (NYSE:AWI), a leader in the design, innovation and manufacture of commercial and residential ceiling, wall and suspension system solutions, today reported financial results for the first quarter of 2020.COVID-19 UpdateIn response to the COVID-19 pandemic, AWI has taken numerous actions to support all of its stakeholders, while operating within CDC guidelines and maintaining...

Continue reading

Amedisys Signs Definitive Agreement to Acquire AseraCare Hospice

BATON ROUGE, La., April 27, 2020 (GLOBE NEWSWIRE) — Amedisys, Inc. (NASDAQ:AMED), a leading provider of home health, hospice and personal care, announced today that it has, through one of its wholly owned subsidiaries, signed a definitive agreement to acquire Homecare Preferred Choice, Inc., doing business as AseraCare Hospice (“AseraCare Hospice”), a national hospice care provider with an executive office in Plano, Texas and administrative support center in Fort Smith, Arkansas. Founded in 1994, AseraCare Hospice cares for more than 2,100 patients daily and employs more than 1,200 hospice professionals in 44 locations across 14 states, generating approximately $117 million in annual revenues.Under the terms of the agreement, expected to close on, or around, June 1, 2020, pending regulatory approvals, Amedisys will acquire 100 percent...

Continue reading

Automotive Lubricants Market Size to Reach USD 79.91 Billion by 2026; Growing Adoption of Synthetic Lubricants to Boost Growth, sates Fortune Business Insights™

Pune, April 27, 2020 (GLOBE NEWSWIRE) — The global automotive lubricants market size is expected to reach USD 79.91 billion by 2026, exhibiting a CAGR of 1.58% during the forecast period. The growing adoption and popularity of synthetic lubricants in the automotive sector will have a positive impact on the automotive lubricants market growth during the forecast period. The growing innovation in lubricants has improved the overall of quality, which has led to extended oil drain and service intervals, better fuel efficiency, and a more extended protection period. This factor will spur demand for lubricants, which in turn, will enable speedy growth of the market. Besides, the increasing awareness regarding the benefits of synthetic lubricants among consumers will aid the market revenue for automotive lubricants in the foreseeable future.According...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.